Cardiovascular Sciences Performance

CVSCDelisted Stock  USD 0.0001  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cardiovascular Sciences are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cardiovascular Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cardiovascular Sciences is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
  

Cardiovascular Sciences Relative Risk vs. Return Landscape

If you would invest  0.01  in Cardiovascular Sciences on November 15, 2025 and sell it today you would earn a total of  0.00  from holding Cardiovascular Sciences or generate 0.0% return on investment over 90 days. Cardiovascular Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Cardiovascular, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Cardiovascular Sciences Target Price Odds to finish over Current Price

The tendency of Cardiovascular Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0001 90 days 0.0001 
about 13.14
Based on a normal probability distribution, the odds of Cardiovascular Sciences to move above the current price in 90 days from now is about 13.14 (This Cardiovascular Sciences probability density function shows the probability of Cardiovascular Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cardiovascular Sciences has the beta coefficient that is very close to zero suggesting the returns on DOW JONES INDUSTRIAL and Cardiovascular Sciences do not appear to be highly-sensitive. Additionally It does not look like Cardiovascular Sciences' alpha can have any bearing on the current valuation.
   Cardiovascular Sciences Price Density   
       Price  

Predictive Modules for Cardiovascular Sciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardiovascular Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiovascular Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000640.00
Details

Cardiovascular Sciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardiovascular Sciences is not an exception. The market had few large corrections towards the Cardiovascular Sciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardiovascular Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardiovascular Sciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.00
β
Beta against Dow Jones0.00
σ
Overall volatility
0.00005
Ir
Information ratio 0.00

Cardiovascular Sciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardiovascular Sciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardiovascular Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cardiovascular Sciences is not yet fully synchronised with the market data
Cardiovascular Sciences has some characteristics of a very speculative penny stock
Cardiovascular Sciences has a very high chance of going through financial distress in the upcoming years
Cardiovascular Sciences currently holds 119.21 K in liabilities. Cardiovascular Sciences has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardiovascular Sciences' use of debt, we should always consider it together with its cash and equity.

Cardiovascular Sciences Fundamentals Growth

Cardiovascular Stock prices reflect investors' perceptions of the future prospects and financial health of Cardiovascular Sciences, and Cardiovascular Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardiovascular Stock performance.

About Cardiovascular Sciences Performance

By analyzing Cardiovascular Sciences' fundamental ratios, stakeholders can gain valuable insights into Cardiovascular Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cardiovascular Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cardiovascular Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 2006. Cardiovascular Sci is traded on OTC Exchange in the United States.

Things to note about Cardiovascular Sciences performance evaluation

Checking the ongoing alerts about Cardiovascular Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardiovascular Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cardiovascular Sciences is not yet fully synchronised with the market data
Cardiovascular Sciences has some characteristics of a very speculative penny stock
Cardiovascular Sciences has a very high chance of going through financial distress in the upcoming years
Cardiovascular Sciences currently holds 119.21 K in liabilities. Cardiovascular Sciences has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardiovascular Sciences' use of debt, we should always consider it together with its cash and equity.
Evaluating Cardiovascular Sciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cardiovascular Sciences' stock performance include:
  • Analyzing Cardiovascular Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardiovascular Sciences' stock is overvalued or undervalued compared to its peers.
  • Examining Cardiovascular Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cardiovascular Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardiovascular Sciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cardiovascular Sciences' stock. These opinions can provide insight into Cardiovascular Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cardiovascular Sciences' stock performance is not an exact science, and many factors can impact Cardiovascular Sciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Cardiovascular Stock

If you are still planning to invest in Cardiovascular Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Sciences' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals